Navigation Links
Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009
Date:10/15/2009

$-- $3,000 Accounts payable 4,439 4,221 Accrued expenses 2,218 2,575 Deferred income 361 1,228 Other long term debt 4,457 4,185 Deferred income taxes 1,200 2,152 6% Series I Convertible preferred stock subject to mandatory redemption -- 3,270 8% Series J Convertible preferred stock subject to mandatory redemption 13,218 11,594 Total Liabilities 25,893 32,225 Stockholders' Equity (DEFICIT) (11,070) 7,401 Total Liabilities, and Stockholders' Equity (DEFICIT) $14,823 $39,626 NUTRITION 21, INC. Consolidated Statements of Operations (In thousands, except share and per share data) (unaudited) Quarter ended Year ended June 30, June 30, 2009 2008 2009 2008 Net sales $5,343 $10,906 $39,257 $46,363 Other revenues 105 139 348 708 Total Revenues 5,448 11,045 39,605 47,071 Costs and Expenses Cost of Revenues 3,233 3,415 16,397 17,609 Advertising & Promotion General and Administrative 3,8961,141 5,3391,429 17,7073,883 33,4786,197 Research and Development 98 110 364 954 Depreciation and Amortization 196 551 1,106
'/>"/>
SOURCE Nutrition 21, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management
2. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
3. Salugen to Present at Nutrition Capital Networks First In-Person Investor Meeting
4. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
5. Pilot Therapeutics Announces New Executive Team with Extensive Experience Creating New Health and Nutrition Businesses
6. Salugen Expands U.S. Distribution and Announces a Partnership with DNA Dimensions to Bring DNA Customized Nutritional Solutions to Metro Detroit Area
7. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
8. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
9. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
10. Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc.
11. Nutrition 21 to Report Second Quarter Fiscal 2008 Financial Results Monday, February 11, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... The report expects global cell isolation ... It also provides a carefully analyzed data about the ... the market. , Full Copy of Report @ ... market for cell expansion will keep witnessing growth at ... growth to be driven by rapid technological advancements, government ...
(Date:12/24/2014)... , Dec. 23, 2014 China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that its majority-owned subsidiary, Shandong Taibang Biological Products ... certification from the China Food and Drug Administration ... facility. As previously disclosed in the Company,s public ...
(Date:12/24/2014)... , December 23, 2014 PharmaBoardroom,s ... , out today and available for free download , ... driving change and growth in the sector today. ... notable successes has been in developing a homegrown pharmaceutical manufacturing ... local production still remains some way off. A cursory comparison ...
(Date:12/24/2014)... 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... a Clinical Trial Application (CTA) with the ... (MHRA) seeking regulatory approval to initiate clinical trials for ... Contingent on the Company receiving CTA regulatory ... trial to assess the safety, tolerability and dose escalation ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... Network,s 3-Minute,Press Show is a daily program hosted by ... company executives on their,company and most recent press releases., ... insight into a company,s,latest news, and its impact on ... Monday through Friday at: http://tv.wallst.net/3-min-press/3-min-press.php , ...
... Gaining a first-cycle,approval for a new molecular ... incremental revenue on average, according to a new ... International (Nasdaq: PRXL ),and leading global life ... According to the PAREXEL Consulting,analysis, 60 percent of ...
... DC The future of how the world ... likely come from the same source: nanotechnology. According ... the Project on Emerging Nanotechnologies (PEN), nanotechnology will ... electronics and "green" energy technologies. , In ...
Cached Biology Technology:[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: IMMU, KYUS 2PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 2PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 3PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 4PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 5
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ... funding to expand its team and bring LaunchKey to ...
(Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... during the Oligocene epoch, some 33.6 million years ago, ... the Andalusian Institute of Earth Sciences (IACT)a Spanish National ... on information contained in ice sediments from different depths, ... ., Before the ice covered Antarctica, the Earth was ...
... a world-leading provider of scientific, technical and medical ... the launch of Translational Proteomics , an ... discoveries in the field of proteomics to clinical ... Jean-Charles Sanchez, Associate Professor at the University ...
... at UC Irvine reported this week that a synthetic compound ... found to enhance metabolic activity and shows potential as a ... published the week of May 27 in the Proceedings ... selectively blocks the activity of a protein that promotes inflammation ...
Cached Biology News:The Antarctic polar icecap is 33.6 million years old 2UCI researchers find sea anemone venom-derived compound effective in anti-obesity studies 2UCI researchers find sea anemone venom-derived compound effective in anti-obesity studies 3
Mouse Cell Line Slides...
Request Info...
Human Cell Line Slides...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets USA ...
Biology Products: